Nlandu Roger Ngatu, Ryoji Hirota, Maiko Kaneko Okajima, Luzitu Severin Nangana, Basilua Andre Muzembo, Masamitsu Eitoku, Okitotsho Stanislas Wembonyama, Tatsuo Kaneko, Benjamin Longo-Mbenza, Narufumi Suganuma
ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL 3(1) 43-49 2014年1月
Vernonia amygdalina Del. is an edible plant which is a member of the Asteracaea family, genus Vernonia, growing in the tropical Africa, whose leaf extracts are used as a remedy for malaria, cough, gastrointestinal disorders and hepatitis, whereas both root and leaf extracts are used to treat fever, hiccups, kidney disease, diabetes and helminthiasis in African ethnomedicine. The plant extracts are reported to contain antioxidant flavonoid compounds(Luteolin, Luteolin 7-Ob-glucoroniside, Luteolin 7-O-b-glucoside) and saponins such as Vernoniosides A1, A2, A3, B1, B2, D3 and C. Their main active sesquiterpenes areVernodalin, Vernodalol, Vernolepin and Vernomygdin and Vernolides. We report on the safety and efficacy of the water and alcoholic extracts of Vernonia amygdalina leaf in children with atopic eczema. In this preliminary clinical trial, 25 atopic eczema or atopic dermatitis (AD) school children (age: 5-17 y) who satisfied entry criteria and completed at least 2 weeks of treatment were considered in this study. Each patient was randomly assigned one of the following topical treatments: water (Vamex1) and ethanol extracts (Vamex2) of V. amygdalina leaf, dexamethasone or Vaseline (5-7 patients/group). Clinical assessment and the evaluation of disease severity were performed once a week using the Eczema Area Severity Index (EASI) scoring system. The treatment was administered topically twice daily; hematological assays and hepatic function assessments were performed.Topical application of Vamex1, Vamex2, as well as dexamethasone, significantly reduced the disease severity (EASI score) (vs. Vaseline; p<0.05); though dexamethasone showed a relatively better effect as compared to Vamex1 and Vamex2, the difference did not reach the significance level. In addition, topical Vamex1 and Vamex2 relieved itch within the second week of treatment (vs. Vaseline; p<0.05). Results from the hematological and immunological assays showed a significant reduction in ESR in Vamex1, Vamex2 and dexamethasone-treated patients (vs. Vaseline; p<0.05), whereas serum transaminases (AST, ALT) remained within normal ranges in all groups after a four-week treatment period. In addition, a decrease in total IgE was noted in dexamethasone and Vamex-treated patients, but not significantly. No side effects related to any of the treatments was noted. Results from this preliminary trial show that topical application of Vernonia amygdalina leaf extracts might be safer and has a potential to serve as natural alternative remedy for mild to moderate atopic dermatitis.